Notice of Change in the Date of Execution of the Share Transfer Concerning the Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. from Tanabe Pharma Corporation (Making It a Wholly Owned Subsidiary)

Updated IR Calendar

Briefing Script and Q&A Summary of financial results meeting for the first quarter of the year ending March 31, 2027

Closed Minamiosaka Branch

Briefing Script and Q&A Summary of briefing on the Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals